The estimated Net Worth of Natalie Mc Clure is at least 260 千$ dollars as of 18 April 2016. Natalie Clure owns over 36,000 units of Adamas Pharmaceuticals Inc stock worth over 260,360$ and over the last 10 years Natalie sold ADMS stock worth over 0$.
Natalie has made over 10 trades of the Adamas Pharmaceuticals Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Natalie exercised 36,000 units of ADMS stock worth 37,800$ on 18 April 2016.
The largest trade Natalie's ever made was exercising 36,000 units of Adamas Pharmaceuticals Inc stock on 18 April 2016 worth over 37,800$. On average, Natalie trades about 8,154 units every 39 days since 2014. As of 18 April 2016 Natalie still owns at least 31,674 units of Adamas Pharmaceuticals Inc stock.
You can see the complete history of Natalie Clure stock trades at the bottom of the page.
Natalie's mailing address filed with the SEC is 1900 Powell St #750, Emeryville, CA 94608, USA.
Over the last 11 years, insiders at Adamas Pharmaceuticals Inc have traded over 26,222,162$ worth of Adamas Pharmaceuticals Inc stock and bought 1,128,061 units worth 17,799,399$ . The most active insiders traders include Point Partners Llcjay Jeffr...、David L Mahoney、William W. Ericson. On average, Adamas Pharmaceuticals Inc executives and independent directors trade stock every 25 days with the average trade being worth of 254,236$. The most recent stock trade was executed by Vijay Shreedhar on 21 June 2021, trading 6,200 units of ADMS stock currently worth 31,992$.
Adamas Pharmaceuticals Inc. delivers innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. The company is a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases.
Adamas Pharmaceuticals Inc executives and other stock owners filed with the SEC include: